Congratulations to the SLAS Europe 2022 Innovation AveNEW lineup:
Causeway Sensors Limited (United Kingdom) - Ignite Award Finalist
Flomics Biotech (Spain)
ICFO (Spain) - Ignite Award Finalist
Inventia Life Science (Australia)
KinCon Biolabs (Austria) - Ignite Award Finalist
Opto Biolabs GmbH (Germany)
SUN Bioscience (Switzerland) - Ignite Award Finalist
Topazium Artificial Intelligence (Spain)
Innovation AveNEW is a program designed for start-up or emerging companies in the life sciences and technologies space. This specially designated area of the exhibition will connect you to purchasing influencers and decision-makers from around the world — at no cost. Companies selected for Innovation AveNEW are given the opportunity to elevate the promotion of their new company, product or service. Innovation AveNEW companies pay no fees and are rewarded with access to a global audience and business consulting, and can opt-in to compete for the SLAS Ignite Award. Innovation AveNEW applications are accepted year-round for the International Conference & Exhibition and the Europe Conference & Exhibition.
Innovation AveNEW companies who opt-in to compete for the SLAS Ignite Award will be judged by an SLAS panel on a combination of key concepts, including their marketing plan, market presence and potential; funding prospects; plan for growth and the existence of balanced company leadership, among other qualities, for a chance to win $5,000.
Brain in a Dish: Neurix SA, 2021 Innovation AveNEW participant
At the Touch of Your Screen: FLUICS GmbH, 2021 Innovation AveNEW participant
Espresso Machine for DNA: Kilobaser GmbH, 2021 Innovation AveNEW participant
Like Recipes in a Kitchen: LabVoice, 2021 Innovation AveNEW participant
The Importance of Science and Health: Newormics, 2021 Innovation AveNEW participant
Mid-Brain Organoids: OrganoTherapeutics, 2021 Innovation AveNEW participant and New Product Award winner
2019 Ignite Award Winner: SEED Biosciences
Interested companies must align in some fashion with the area of life sciences and technology and while not required, an established relationship with a university, bioscience incubator or research institution is preferable. The company’s products and/or services must be available for sale/distribution within the year of their conference participation.
All applications are reviewed by the Innovation AveNEW Review Panel, who will evaluate applications for technical merit and commercial feasibility as well as other criteria, inclusive of, but not limited to:
SLAS reserves the right to select and deselect any company at any given time. All decisions are final. Companies selected for participation in Innovation AveNEW must agree to and adhere to the rules and regulations for participation.
SLAS is dedicated to advancing life sciences discovery and technology and connecting its users to each other. To fulfill that mission, companies selected to participate in Innovation AveNEW receive at no cost:
Deadline for Innovation AveNEW Applicants — Monday, 4 April
Need more information? Contact Elizabeth Frank, Program Manager or at +1.630.256.SLAS (7527) ext. 102.